The Addison's Disease Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Addison's Disease Market?
The market size for Addison's disease has seen rapid expansion recently. The market was at $2.05 billion in 2024 and is predicted to reach $2.25 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Addison's Disease Industry?
The Addison's Disease Global Market Report 2025 projects that by the year 2029, the market size will reach $3.26 billion, growing at a compound annual growth rate (CAGR) of 9.7%.
Download Your Free Sample of the 2025 Addison's Disease Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Addison's Disease Market?
The key drivers in the addison's disease market are:
• Rising demand for advanced therapeutics
• Increasing emphasis on early diagnosis
• Growth in congenital adrenal hyperplasia cases
• Expansion of telemedicine services and rise in adrenal tuberculosis cases
Global Market Segmentation: Identifying Major Addison's Disease Industry Segments
The addison's disease market covered in this report is segmented –
1) By Type: Primary Adrenal Insufficiency, Secondary Adrenal Insufficiency, Tertiary Adrenal Insufficiency
2) By Drug Class: Oral Corticosteroid, Hydrocortisone, Fludrocortisone, Corticosteroid Injections
3) By Diagnosis: Laboratory Testing, Imaging Testing
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Primary Adrenal Insufficiency: Autoimmune Addison's Disease, Infectious Addison's Disease, Other causes of primary adrenal insufficiency
2) By Secondary Adrenal Insufficiency: Pituitary gland dysfunction, Hypothalamic dysfunction
3) By Tertiary Adrenal Insufficiency: Hypothalamic or pituitary suppression due to long-term steroid use, Other causes of tertiary adrenal insufficiency
Pre-order the 2025 Addison's Disease Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Addison's Disease Market?
The key trends in the addison's disease market are:
• Laboratory testing methodologies are being enhanced and modernized.
• Advances are being made in hormone replacement therapies.
• Imaging technologies are undergoing significant development.
• There's a trend towards the development of long-acting injectable formulations and integrating artificial intelligence into diagnostic tools.
Who Are the Top Competitors & Leading Players in the Addison's Disease Market?
Major players in the addison's disease market are:
• Pfizer Inc.
• Roche Holding AG
• Merck & Co. Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• Novartis AG
• Takeda Pharmaceutical Company Limited
• GlaxoSmithKline plc
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Sandoz
• Ipsen S.A.
• Neurocrine Biosciences Inc.
• Recipharm AB
• Accord Healthcare
• Eton Pharmaceuticals
• DuoCort Pharma
• Diurnal Group plc
• Roxane Laboratories Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the addison's disease market in 2024
